Absorption Systems, LP announced the acquisition of Perry Scientific, Inc, an in vivo toxicology and pharmacokinetics testing company located in San Diego, California. Perry's research services include testing for toxicology, medical devices, preclinical models and CNS pharmacology. These services complement Absorption Systems' portfolio of products and services, which provide definitive data regarding the absorption, distribution, metabolism and excretion, or ADME properties, of small molecules in order to help pharmaceutical companies advance their new drug candidates toward clinical testing and ultimately, regulatory approval.

"The acquisition of Perry Scientific furthers our mission to efficiently move clients from the early stages of drug discovery testing for ADME and pharmacokinetics through the definitive safety and toxicology testing necessary for new drug and device submissions," commented Patrick M Dentinger, president and CEO of Absorption Systems. "By offering a full range of tests, we will be able to design and perform studies that will get clients to the point of submission to the FDA as quickly as possible."

In addition to routine preclinical pharmacokinetics testing, Absorption Systems will conduct studies in compliance with Good Laboratory Practices (GLP) in the San Diego testing facility, which is fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International. Increasingly, pharmaceutical companies are opting to work only with facilities that are AAALAC accredited. The combined entity will be the only Contract Research Organization (CRO) in Southern California that can offer a full range of pharmacokinetic and toxicology studies, including the dose vehicle development and optimization, dosing and analytical phases of the studies.

Perry Scientific is the oldest and largest CRO in Southern California. It was founded in 1999 to perform preclinical studies for the biotech and pharmaceutical industries and has grown to a national company with customers throughout the US.

"Joining forces with Absorption Systems is a natural step in our growth because our respective businesses are entirely complementary," said Andrew Perry, the founder of Perry Scientific. Now we can offer our customers the convenience and accuracy of having an entire preclinical testing package performed at a single facility-the combined company offers all the services needed to move a new drug from the benchtop to the clinic."

Founded in 1996 by Patrick Dentinger and Ismael J Hidalgo, Absorption Systems, LP (ASLP) focuses on performing assays (analyses) that can predict the Absorption, Distribution, Metabolism and Excretion (ADME) of small molecules using a variety of in vitro, in situ, and in vivo models.